The Food and Drug Administration (FDA) has turned its attention to Novo Nordisk’s splashy oral Wegovy campaign, just one month after the weight loss pill launched in the U.S. The agency sent Novo an ...

The U.S. Food and Drug Administration (FDA) has accused Novo Nordisk (NVO) (NONOF) of violating federal law by including “misleading” claims in a TV commercial for its recently launched oral weight ...

Add Yahoo as a preferred source to see more of our stories on Google. In this print ad, Fortune 500 Europe company Novo Nordisk promotes semaglutide safety. The pharmaceutical giant markets the drug ...

One doctor is losing her lunch over a bizarre ad in the window of a new pizza-bagel joint in Midtown that encourages people to take a popular weight-loss drug after wolfing down a meal there. “Bagizza ...

It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown for compounders to stop selling their versions of semaglutide. Now that the ...

Add Yahoo as a preferred source to see more of our stories on Google. DJ Khaled wants to shout from the rooftops about the benefits of the new Wegovy pill. The “We The Best” rapper/producer is one of ...

In a letter sent last week, the US Food and Drug Administration (FDA) said that a TV ad for Novo Nordisk's Wegovy (semaglutide) tablets misleads consumers into thinking the pill is better than other ...

Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the ...